Overview
Background
After completing an honours year in genetics in the lab of Professor Paul Ebert (The University of Queensland), Dr Fotheringham obtained a research assistant position in the field of diabetes, sparking a passionate interest in diabetes and diabetes complications, particularly diabetic nephropathy. This led her to undertake and complete a PhD, examining the influence of dietary factors, in particularly advanced glycation end products and macronutrients on renal function in diabetes and aging. Since completing her PhD in 2020, Dr Amelia Fotheringham has worked as a Research Officer in the Glycation and Diabetes Complications Laboratory at Mater Research-UQ. Here she has undertaken projects examining novel treatments for mitochondrial dysfunction in diabetic nephropathy and targeting the AGE-RAGE pathway for type 1 diabetes prevention.
Availability
- Dr Amelia Fotheringham is:
- Available for supervision
Works
Search Professor Amelia Fotheringham’s works on UQ eSpace
2014
Conference Publication
Flux of advanced glycation end products across the kidney as a contributor to renal disease in diabetes
Leung, C., Fotheringham, A. K., Zhuang, A., Borg, D. J., Ward, M. S., Coughlan, M. T., Mccarthy, D. A., Gallo, L. A., Harcourt, B. E. and Forbes, J. M. (2014). Flux of advanced glycation end products across the kidney as a contributor to renal disease in diabetes. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12302
2014
Conference Publication
Glyoxalase-1 Inhibition Leads to Podocyte Insulin Resistance and Features Resembling Diabetic Kidney Disease
Gallo, Linda A., Ward, Micheal S., Harcourt, Brooke E., Fotheringham, Amelia K., McCarthy, Domenica A., Penfold, Sally A. and Forbes, Josephine M. (2014). Glyoxalase-1 Inhibition Leads to Podocyte Insulin Resistance and Features Resembling Diabetic Kidney Disease. 14th Asian Pacific Congress of Nephrology, Tokyo, Japan, 14-17 May 2014. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/nep.12236
2014
Conference Publication
Mitochondrial targeting of superoxide by Mitoq improves metabolic renal dysfunction
Ward, M. S., Flemming, N. B., Gallo, L. A., Fotheringham, A., Gobe, G., Vesey, D. and Forbes, J. M. (2014). Mitochondrial targeting of superoxide by Mitoq improves metabolic renal dysfunction. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne Australia, 25–27 August 2014. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301
2013
Journal Article
Rapid genome wide mapping of phosphine resistance loci by a simple regional averaging analysis in the red flour beetle, Tribolium castaneum
Jagadeesan, Rajeswaran, Fotheringham, Amelia, Ebert, Paul R. and Schlipalius, David I. (2013). Rapid genome wide mapping of phosphine resistance loci by a simple regional averaging analysis in the red flour beetle, Tribolium castaneum. Bmc Genomics, 14 (1) 650, 650.1-650.11. doi: 10.1186/1471-2164-14-650
2013
Journal Article
Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease
Ward, Micheal S., Fortheringham, Amelia K., Cooper, Mark E . and Forbes, Josephine M. (2013). Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease. Current Opinion in Pharmacology, 13 (4), 654-661. doi: 10.1016/j.coph.2013.06.009
2013
Conference Publication
Methylglyoxal induced insulin resistance in podocytes contributes to diabetic kidney disease
Gallo, L. A., Harcourt, B. E., Fotheringham, A. K., McCarthy, D., Penfold, S. A. and Forbes, J. M. (2013). Methylglyoxal induced insulin resistance in podocytes contributes to diabetic kidney disease. 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, Spain, 23 -27 September 2013. Heidelberg, Germany: Springer. doi: 10.1007/s00125-013-3012-z
2013
Conference Publication
Therapies which lower advanced glycation end products influence experimental autoimmune diabetes in a time dependent manner
Borg, D. J., Yap, F. Y. T., Fotheringham, A. K., Harcourt, B. E., McCarthy, D., Ward, M., Slattery, R., Coughlan, M. T., Kantharidis, P. and Forbes, J. M. (2013). Therapies which lower advanced glycation end products influence experimental autoimmune diabetes in a time dependent manner. 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, Spain, 23 -27 September 2013. Heidelberg, Germany: Springer. doi: 10.1007/s00125-013-3012-z
2013
Conference Publication
Oligosaccharyltransferase-48 as a Novel Mediator of Chronic Kidney Disease in Diabetes
Zhuang, A., Harcourt, B., Sourris, K., Penfold, S., Ward, M., Fotheringham, A., Thorn, P. and Forbes, J. (2013). Oligosaccharyltransferase-48 as a Novel Mediator of Chronic Kidney Disease in Diabetes. WILEY-BLACKWELL.
Funding
Past funding
Supervision
Availability
- Dr Amelia Fotheringham is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
The receptor for advanced glycation end products and its role in Type 1 diabetes development
Associate Advisor
Other advisors: Professor Emma Hamilton-Williams, Dr Irina Buckle, Dr Sherman Leung, Honorary Professor Josephine Forbes
-
Doctor Philosophy
The Characterisation of Immune Cells in Response To RAGE Antagonism Therapy in Mouse Models of Type 1 Diabetes
Associate Advisor
Other advisors: Professor Benjamin Schulz, Honorary Professor Josephine Forbes, Dr Irina Buckle
-
Doctor Philosophy
sRAGE as a preventative therapy for T1D and potential biomarker of pregnancy complications
Associate Advisor
Other advisors: Professor Emma Hamilton-Williams, Dr Irina Buckle, Dr Sherman Leung, Honorary Professor Josephine Forbes
-
Doctor Philosophy
Early mitochondrial dysfunction in diabetic kidney
Associate Advisor
Other advisors: Dr Irina Buckle, Honorary Professor Josephine Forbes
Media
Enquiries
For media enquiries about Dr Amelia Fotheringham's areas of expertise, story ideas and help finding experts, contact our Media team: